ZPC-14342-84756 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-23
Registered in v-safe
2020-12-23
Dose 1 — Pfizer-BioNTech
2020-12-25
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activities

Free text: Axillary Lymphadenopathy (localized to arm I received vaccine in)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-25
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2020-12-26
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain

Free text: Axillary lymphadenopathy (localized to same side that vaccine was given in), improved from yesterday

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-27
Survey response — days 1–6 daily, dose 1
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Axillary lymphadenopathy

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-06
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-12
Dose 2 — Pfizer-BioNTech
2021-01-12
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain · Muscle or body aches

Adult check-in
2021-01-13
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness

Adult check-in
2021-01-14
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain · Fever · Muscle or body aches

Free text: Axillary lymphadenopathy (same side vaccine was given in)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-15
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good · Site: Pain

Free text: Axillary lymphadenopathy (on side of vaccine)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Good

Free text: Axillary lymphadenopathy (same side as vaccine)

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-18
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-01-26
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-02-04
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-09
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-02-18
Survey response — day 35, dose 2
MedDRA: Pre-existing disease, Urticaria — Feeling: Good

Free text: Almost daily urticaria, did have some of this before the vaccine dosing but it has acutely worsened in the last two-three weeks. It certainly could be unrelated

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-23
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-13
Health check-in — 3 months, dose 2
Feeling: Good

Adult check-in
2021-07-13
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-14
Survey response — 12 months, dose 2
MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Diagnosed with COVID-19

MedDRA releases: 2024-11 · check-in free text available

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-23	Pfizer-BioNTech
2	2021-01-12	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2020-12-25	priority 2/3

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-25

Systemic reaction (other): Axillary Lymphadenopathy (localized to arm I received vaccine in)

2020-12-26

Systemic reaction (other): Axillary lymphadenopathy (localized to same side that vaccine was given in), improved from yesterday

2020-12-27

Systemic reaction (other): Axillary lymphadenopathy

Release 2 — days 1–6 daily, dose 2

2021-01-14

Systemic reaction (other): Axillary lymphadenopathy (same side vaccine was given in)

2021-01-15

Systemic reaction (other): Axillary lymphadenopathy (on side of vaccine)

2021-01-16

Systemic reaction (other): Axillary lymphadenopathy (same side as vaccine)

Release 4 — day 35, dose 2

2021-02-18

Symptoms: Almost daily urticaria, did have some of this before the vaccine dosing but it has acutely worsened in the last two-three weeks. It certainly could be unrelated

Release 10 — 12 months, dose 2

2022-01-14

Symptoms: Diagnosed with COVID-19

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	COVID-19	·	·	✓
SD	Pre-existing disease	✓	✓	✓
SD	Urticaria	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release